Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) Return on Equity (2019 - 2025)

Historic Return on Equity for aTYR PHARMA (ATYR) over the last 7 years, with Q3 2025 value amounting to 1.01%.

  • aTYR PHARMA's Return on Equity fell 900.0% to 1.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.01%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.85% for FY2024, which is 1700.0% down from last year.
  • According to the latest figures from Q3 2025, aTYR PHARMA's Return on Equity is 1.01%, which was down 900.0% from 0.93% recorded in Q2 2025.
  • In the past 5 years, aTYR PHARMA's Return on Equity ranged from a high of 0.06% in Q3 2021 and a low of 1.01% during Q3 2025
  • Moreover, its 5-year median value for Return on Equity was 0.46% (2022), whereas its average is 0.55%.
  • Its Return on Equity has fluctuated over the past 5 years, first skyrocketed by 4300bps in 2021, then tumbled by -4700bps in 2024.
  • Over the past 5 years, aTYR PHARMA's Return on Equity (Quarter) stood at 0.06% in 2021, then tumbled by -631bps to 0.46% in 2022, then decreased by -28bps to 0.58% in 2023, then crashed by -73bps to 1.0% in 2024, then decreased by -1bps to 1.01% in 2025.
  • Its last three reported values are 1.01% in Q3 2025, 0.93% for Q2 2025, and 0.92% during Q1 2025.